127 related articles for article (PubMed ID: 16516257)
41. Improved adenovirus type 5 vector-mediated transduction of resistant cells by piggybacking on coxsackie B-adenovirus receptor-pseudotyped baculovirus.
Granio O; Porcherot M; Corjon S; Kitidee K; Henning P; Eljaafari A; Cimarelli A; Lindholm L; Miossec P; Boulanger P; Hong SS
J Virol; 2009 Jun; 83(12):6048-66. PubMed ID: 19357170
[TBL] [Abstract][Full Text] [Related]
42. Simultaneous CAR- and alpha V integrin-binding ablation fails to reduce Ad5 liver tropism.
Martin K; Brie A; Saulnier P; Perricaudet M; Yeh P; Vigne E
Mol Ther; 2003 Sep; 8(3):485-94. PubMed ID: 12946322
[TBL] [Abstract][Full Text] [Related]
43. Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates.
Smith TA; Idamakanti N; Marshall-Neff J; Rollence ML; Wright P; Kaloss M; King L; Mech C; Dinges L; Iverson WO; Sherer AD; Markovits JE; Lyons RM; Kaleko M; Stevenson SC
Hum Gene Ther; 2003 Nov; 14(17):1595-604. PubMed ID: 14633402
[TBL] [Abstract][Full Text] [Related]
44. CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors.
Alemany R; Curiel DT
Gene Ther; 2001 Sep; 8(17):1347-53. PubMed ID: 11571572
[TBL] [Abstract][Full Text] [Related]
45. Adenovirus type 5 pseudotyped with adenovirus type 37 fiber uses sialic acid as a cellular receptor.
Cashman SM; Morris DJ; Kumar-Singh R
Virology; 2004 Jun; 324(1):129-39. PubMed ID: 15183060
[TBL] [Abstract][Full Text] [Related]
46. Adenovirus vectors based on human adenovirus type 19a have high potential for human muscle-directed gene therapy.
Thirion C; Lochmüller H; Ruzsics Z; Boelhauve M; König C; Thedieck C; Kutik S; Geiger C; Kochanek S; Volpers C; Burgert HG
Hum Gene Ther; 2006 Feb; 17(2):193-205. PubMed ID: 16454653
[TBL] [Abstract][Full Text] [Related]
47. Adenovirus vectors containing chimeric type 5 and type 35 fiber proteins exhibit altered and expanded tropism and increase the size limit of foreign genes.
Mizuguchi H; Hayakawa T
Gene; 2002 Feb; 285(1-2):69-77. PubMed ID: 12039033
[TBL] [Abstract][Full Text] [Related]
48. Genetic manipulations of adenovirus type 5 fiber resulting in liver tropism attenuation.
Vigne E; Dedieu JF; Brie A; Gillardeaux A; Briot D; Benihoud K; Latta-Mahieu M; Saulnier P; Perricaudet M; Yeh P
Gene Ther; 2003 Jan; 10(2):153-62. PubMed ID: 12571644
[TBL] [Abstract][Full Text] [Related]
49. Gene transfer to carcinoma of the breast with fiber-modified adenoviral vectors in a tissue slice model system.
Stoff-Khalili MA; Stoff A; Rivera AA; Mathis JM; Everts M; Wang M; Kawakami Y; Waehler R; Mathews QL; Yamamoto M; Rocconi RP; Siegal GP; Richter DF; Dall P; Zhu ZB; Curiel DT
Cancer Biol Ther; 2005 Nov; 4(11):1203-10. PubMed ID: 16177567
[TBL] [Abstract][Full Text] [Related]
50. Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors.
Shayakhmetov DM; Li ZY; Ni S; Lieber A
J Virol; 2004 May; 78(10):5368-81. PubMed ID: 15113916
[TBL] [Abstract][Full Text] [Related]
51. Ovine atadenovirus, a novel and highly immunogenic vector in prime-boost studies of a candidate HIV-1 vaccine.
Bridgeman A; Roshorm Y; Lockett LJ; Xu ZZ; Hopkins R; Shaw J; Both GW; Hanke T
Vaccine; 2009 Dec; 28(2):474-83. PubMed ID: 19853074
[TBL] [Abstract][Full Text] [Related]
52. A novel system to study adenovirus tropism to normal and malignant colon tissues.
Kolodkin-Gal D; Zamir G; Pikarski E; Pikarski A; Shimony N; Wu H; Haviv YS; Panet A
Virology; 2007 Jan; 357(1):91-101. PubMed ID: 16962151
[TBL] [Abstract][Full Text] [Related]
53. Construction, rescue, and characterization of vectors derived from ovine atadenovirus.
Löser P; Hofmann C; Both GW; Uckert W; Hillgenberg M
J Virol; 2003 Nov; 77(22):11941-51. PubMed ID: 14581531
[TBL] [Abstract][Full Text] [Related]
54. Enhanced adenovirus infection of melanoma cells by fiber-modification: incorporation of RGD peptide or Ad5/3 chimerism.
Volk AL; Rivera AA; Kanerva A; Bauerschmitz G; Dmitriev I; Nettelbeck DM; Curiel DT
Cancer Biol Ther; 2003; 2(5):511-5. PubMed ID: 14614316
[TBL] [Abstract][Full Text] [Related]
55. Subgroup B and F fiber chimeras eliminate normal adenovirus type 5 vector transduction in vitro and in vivo.
Schoggins JW; Gall JG; Falck-Pedersen E
J Virol; 2003 Jan; 77(2):1039-48. PubMed ID: 12502819
[TBL] [Abstract][Full Text] [Related]
56. Targeting of adenovirus serotype 5 (Ad5) and 5/47 pseudotyped vectors in vivo: fundamental involvement of coagulation factors and redundancy of CAR binding by Ad5.
Waddington SN; Parker AL; Havenga M; Nicklin SA; Buckley SM; McVey JH; Baker AH
J Virol; 2007 Sep; 81(17):9568-71. PubMed ID: 17553882
[TBL] [Abstract][Full Text] [Related]
57. Development of adenovirus serotype 35 as a gene transfer vector.
Seshidhar Reddy P; Ganesh S; Limbach MP; Brann T; Pinkstaff A; Kaloss M; Kaleko M; Connelly S
Virology; 2003 Jul; 311(2):384-93. PubMed ID: 12842627
[TBL] [Abstract][Full Text] [Related]
58. Mouse adenovirus type 1 and human adenovirus type 5 differ in endothelial cell tropism and liver targeting.
Lenaerts L; McVey JH; Baker AH; Denby L; Nicklin S; Verbeken E; Naesens L
J Gene Med; 2009 Feb; 11(2):119-27. PubMed ID: 19065608
[TBL] [Abstract][Full Text] [Related]
59. Biodistribution and inflammatory profiles of novel penton and hexon double-mutant serotype 5 adenoviruses.
Bradshaw AC; Coughlan L; Miller AM; Alba R; van Rooijen N; Nicklin SA; Baker AH
J Control Release; 2012 Dec; 164(3):394-402. PubMed ID: 22626939
[TBL] [Abstract][Full Text] [Related]
60. Defining a Novel Role for the Coxsackievirus and Adenovirus Receptor in Human Adenovirus Serotype 5 Transduction
Lopez-Gordo E; Doszpoly A; Duffy MR; Coughlan L; Bradshaw AC; White KM; Denby L; Nicklin SA; Baker AH
J Virol; 2017 Jun; 91(12):. PubMed ID: 28381574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
